Idiopathic Hypersomnia Clinical Trials

53 clinical trials for Idiopathic Hypersomnia across international registries, including 17 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) — RECRUITING · PHASE3
• A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia — RECRUITING · PHASE2
• A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia — RECRUITING · PHASE2
• A Study of TAK-360 in Adults With Idiopathic Hypersomnia — RECRUITING · PHASE2
• A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia — RECRUITING · PHASE2
• Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments — RECRUITING
• Deciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia — RECRUITING · NA
• Low Sodium Oxybate in Patients With Idiopathic Hypersomnia — RECRUITING · PHASE4
• A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia — RECRUITING · PHASE2
• A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia — RECRUITING · PHASE2
• A LONG-TERM EXTENSION STUDY OF THE SAFETY AND EFFICACY OF CLEMINOREXTON IN PARTICIPANTS WITH NARCOLEPSY AND IDIOPATHIC HYPERSOMNIA WHO COMPLETED A SPONSORED CLEMINOREXTON CLINICAL TRIAL — RECRUITING
• A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia — RECRUITING · NA
• a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial — RECRUITING · PHASE2
• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford — RECRUITING
• A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ORX750 IN SUBJECTS WITH NARCOLEPSY AND IDIOPATHIC HYPERSOMNIA ¿ (CRYSTAL-1) — RECRUITING · PHASE2
• Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions — RECRUITING · NA
• Mainz Register of Patients With Sleep Disorders — RECRUITING
• A study in patients with idiopathic hypersomnia involving two parts. Part A is an an open-label study to assess safety, tolerability and pharmacokinetics of a single oral GR3027 dose in female patients. Part B is a randomized, double-blind, placebo-controlled crossover study to assess safety, tolerability, exposure and exploratory efficacy of multiple oral doses of GR3027 in male and female IH patients. — COMPLETED · PHASE2
• Hypersomnia in the Paediatric Population — NOT_YET_RECRUITING · NA
• Clarithromycin Mechanisms in Hypersomnia Syndromes — COMPLETED · PHASE2
• A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia — TERMINATED · PHASE2
• A randomized, double-blind, placebo-controlled trial comparing the efficacy and tolerance of solriamfetol in patients affected with idiopathic hypersomnia. SOLR-IH — NOT_YET_RECRUITING · PHASE2
• The impact of ketogenic diet and physical exercise on narcolepsy type 2 and idiopathic hypersomnia: a randomized, controlled trial — OTHER
• A Dose-Finding, Adaptive, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Efficacy of TAK-360 in Participants with Idiopathic Hypersomnia (IH) — TERMINATED · PHASE2
• Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence — COMPLETED · NA
• Study of SDX in Patients With Idiopathic Hypersomnia (IH) — COMPLETED · PHASE2
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF HBS-301 IN PARTICIPANTS WITH IDIOPATHIC HYPERSOMNIA (IH) FOLLOWED BY AN OPEN-LABEL EXTENSION — NOT_YET_RECRUITING · PHASE3
• A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH — NOT_YET_RECRUITING · PHASE3
• Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ) — COMPLETED · PHASE3
• Improving Social Relationships for Adolescents With Central Disorders of Hypersomnolence — COMPLETED · NA
• Salivary cortisol assessment among individuals with idiopathic hypersomnia to exclude HPA axis dysfunction — NOT_YET_RECRUITING
• A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia — COMPLETED · PHASE3
• Effect of Low Sodium Oxybate (LXB) on Autonomic Symptom Burden in Idiopathic Hypersomnia Patients With Postural Tachycardia Syndrome — NOT_YET_RECRUITING · PHASE4
• A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy — COMPLETED · PHASE4
• Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia — NOT_YET_RECRUITING · PHASE1
• A CHRONOBIOLOGICAL TREATMENT combining evening melatonin and morning light therapy IN IDIOPATHIC HYPERSOMNIA: a prospective, double bind, randomized, placebo-controlled -trial — TERMINATED · PHASE2
• A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia — COMPLETED · PHASE3
• Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia. — NOT_YET_RECRUITING · PHASE2
• Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia — COMPLETED · PHASE2
• Local Sleep in Idiopathic Hypersomnia — OTHER · NA
• Sodium Oxybate in Idiopathic Hypersomnia — COMPLETED · PHASE2
• A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia — COMPLETED · PHASE1
• A PROSPECTIVE, OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO EVALUATE THE EFFECT OF LOW-SODIUM OXYBATE ORAL SOLUTION (XYWAV) ON SLEEPINESS, POLYSOMNOGRAPHY, AND FUNCTIONAL OUTCOMES IN ADULT PARTICIPANTS AGED 18 TO 75 YEARS WITH IDIOPATHIC HYPERSOMNIA OR NARCOLEPSY — COMPLETED
• Psychiatric Co-morbidities and Socio-demographic Characteristics in Patients With Idiopathic Hypersomnia — OTHER
• International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study — OTHER
• A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension — COMPLETED · PHASE3
• Anesthetic Management of Patients With Chronic Sleep Disorders — COMPLETED
• The Role of the Circadian System in Neurological Sleep-wake Disorders — COMPLETED · NA
• A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia — OTHER · PHASE2
• Psychosocial Adjunctive Treatment for Hypersomnia (PATH) — COMPLETED · NA

Refine this search